Friday, 3 July 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 03 July 2026
News

Haemophilia market heats up

Posted 3 July 2026 AM

Last week the TGA approved Sanofi’s pegged blockbuster Altuviiio, adding to a growing list of haemophilia A treatment options in Australia, with the French pharma “working with urgency” to ensure equitable access, according to ANZ Country Lead and Head of Pharma, Liz Selby.

“The registration of Altuviiio marks an exciting milestone for the haemophilia community in Australia. It reflects Sanofi’s commitment to chasing the miracles of science that address unmet need,” Selby added.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (26)

Access & Reimbursement (2)

Clinical & Medical, R&D (7)

Regulatory, Pharmacovigilance & QA (6)

Other (9)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.